Health
Rutgers leading a clinical trial assessing combination treatment for coronavirus – News-Medical.Net
Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with…
Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with SARS-CoV-2 and are asymptomatic or mildly symptomatic. The trial is being conducted with Synavir Corporation, a global health company that works with academia, industry and government to develop combination treatments for new viral infections.
The trial — called Triple Combination Antiviral Coronavirus Therapy (TriACT) — seeks to determine…
-
Noosa News18 hours agoInvestigations underway after dead body found on Townsville road
-
General23 hours agoExtermination efforts continue after invasive ghost snail detection at Port of Brisbane
-
Business23 hours agoI think these are two of the best ASX ETFs to buy in 2025
-
General24 hours agoAustralia’s Iran embassy staff leave after US warning